Contrasting Elevance Health (ELV) and Its Peers

Elevance Health (NYSE:ELV) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it contrast to its competitors? We will compare Elevance Health to related businesses based on the strength of its dividends, analyst recommendations, valuation, institutional ownership, earnings, risk and profitability.

Earnings and Valuation

This table compares Elevance Health and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Elevance Health	$199.12 billion	$5.66 billion	17.99
Elevance Health Competitors	$21.12 billion	$301.67 million	-1.67

Elevance Health has higher revenue and earnings than its competitors. Elevance Health is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Elevance Health and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.55%	14.97%	5.31%
Elevance Health Competitors	-8.06%	-136.95%	-1.64%

Dividends

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.6%. Elevance Health pays out 29.3% of its earnings in the form of a dividend. As a group, “Healthcare Providers & Services” companies pay a dividend yield of 1.4% and pay out 24.7% of their earnings in the form of a dividend. Elevance Health has increased its dividend for 14 consecutive years.

Analyst Recommendations

This is a summary of current ratings and price targets for Elevance Health and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0	7	15	0	2.68
Elevance Health Competitors	1873	7748	13377	829	2.55

Elevance Health presently has a consensus price target of $456.48, suggesting a potential upside of 8.20%. As a group, “Healthcare Providers & Services” companies have a potential upside of 14.73%. Given Elevance Health’s competitors higher probable upside, analysts plainly believe Elevance Health has less favorable growth aspects than its competitors.

Insider and Institutional Ownership

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 0.3% of Elevance Health shares are held by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Risk & Volatility

Elevance Health has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500. Comparatively, Elevance Health’s competitors have a beta of 0.98, indicating that their average share price is 2% less volatile than the S&P 500.

Summary

Elevance Health beats its competitors on 10 of the 15 factors compared.

Elevance Health Company Profile

Elevance Health, Inc. is a U.S. health benefits and services company. Formerly known as Anthem, Inc., it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans. The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business.